Remote Evaluation and Alerting for Collaborative Health (REACH) in Depression
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDartmouth-Hitchcock Medical Center
About this trial
Researchers hope to see if the data smartphones collect continuously can be used to predict if patient's depression symptoms will return. They will do this by collecting data from patient's smartphones and comparing it to their depression symptoms. If this method is successful, researchers could develop a smartphone application to help healthcare providers better monitor patient's depression and intervene earlier if symptoms return.
Eligibility criteria
Qualifiers
Adult patients (18 years or older)
Treated for depression within Dartmouth Health collaborative care model (CoCM) sites who are discharged from CoCM without depression (PHQ-9 < 10)
Have access to and ability to use a smartphone (Android version ≥ 6 or iOS version ≥ 11).
Disqualifiers
Identified as high risk due to active suicidality, psychosis, or bipolar disorder - Discharged from CoCM with ongoing depressive symptoms (PhQ-9 > 10
Trial design
Treatments tested in this trial
- MoodTriggers Application
Treatment groups
320 Participants
are divided into 3 treatment groupsSponsors and collaborators
Dartmouth-Hitchcock Medical Center
Lead sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator
Source ClinicalTrials.gov